menu
    • menu

    Company profile for SkinJect

    NEW Drugs in Dev: 3
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SkinJect is a groundbreaking drug delivery system where the needles themselves are the drug. The device uses a dissolvable microneedle array (MNA) to deliver chemotherapy directly into the top layer of the skin, targeting non-melanoma skin cancer. This localized delivery not only kills cancer cells but also triggers a beneficial immune response.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SkinJectUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    285 Kappa Drive, Suite 100, Pittsburgh PA 15238
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.skinjectpatch.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/skinject
    youtube
    YouTube
    Twitter
    Twitter
    https://twitter.com/SkinJectPatch

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Bio-Europe Spring

    Bio-Europe Spring

    Not Confirmed

    envelop Contact Supplier

    Bio-Europe Spring

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medicus SkinJect Ph2 Shows 80% ORR With KOL Validation
    Medicus SkinJect Ph2 Shows 80% ORR With KOL Validation

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264524/0/en/Medicus-Pharma-Reports-KOL-Validation-of-SkinJect-Phase-2-Data-of-80-Overall-Response-Rate.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Medicus Pharma: 80% ORR in Phase 2 SkinJect, Unveils AI Platform
    Medicus Pharma: 80% ORR in Phase 2 SkinJect, Unveils AI Platform

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3262893/0/en/Medicus-Pharma-Business-Update-Call-to-Highlight-80-Overall-Response-Rate-ORR-in-Phase-2-SkinJect-Study-and-Agentic-AI-enabled-Drug-Development-Plan.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Medicus Pharma To Present Skinject(R) Phase 2 Results
    Medicus Pharma To Present Skinject(R) Phase 2 Results

    18 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-18/medicus-pharma-to-discuss-positive-skinject-r-phase-2-topline-results-in-fireside-chat-hosted-by-br

    PHARMIWEB
    18 Mar 2026
    Share Share
    Medicus Pharma Announces SkinJect Phase 2 Data Review
    Medicus Pharma Announces SkinJect Phase 2 Data Review

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256157/0/en/Medicus-Pharma-Announces-SkinJect-Phase-2-Principal-Investigator-and-Key-Opinion-Leader-KOL-Babar-K-Rao-MD-FAAD-to-Provide-Clinical-Interpretation-of-Positive-Data-During-Business-.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Medicus Pharma Interprets Positive Skinject Phase 2 Data
    Medicus Pharma Interprets Positive Skinject Phase 2 Data

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251726/0/en/Medicus-Pharma-Provides-Interpretation-of-Positive-Phase-2-SkinJect-Dataset.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Medicus Pharma Unveils SkinJect Phase 2 at Biotech Showcase 2026
    Medicus Pharma Unveils SkinJect Phase 2 at Biotech Showcase 2026

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212643/0/en/Medicus-Pharma-Ltd-to-Present-at-Biotech-Showcase-2026-as-SkinJect-Phase-2-Clinical-Data-Approaches-Readout-and-Partnering-Readiness-Accelerates.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search